首页> 美国卫生研究院文献>World Journal of Surgical Oncology >Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

【2h】

Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

机译：Phospho-p44 / 42和pAKT在以蒽环类为基础的新辅助化疗治疗的HER2阳性局部晚期乳腺癌患者中的预后和预测价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundTo evaluate the predictive and prognostic value of various molecular factors associated with the Ras/MAPK and PI3K/Akt signaling pathways in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy (NAC).

机译：背景为了评估与Ras / MAPK和PI3K / Akt信号通路相关的各种分子因素在以蒽环类为基础的新辅助化疗（NAC）治疗的HER2阳性局部晚期乳腺癌患者中的预测和预后价值。

著录项

期刊名称 World Journal of Surgical Oncology
作者
Liang Huang; Tianwen Chen; Canming Chen; Sheng Chen; Yin Liu; Jiong Wu; Zhiming Shao;
展开▼
作者单位

展开▼
年(卷),期 2013(11),-1
年度 2013
页码 307
总页数 9
原文格式 PDF
正文语种
中图分类外科学;肿瘤学;
关键词
Breast cancer HER2eu Neoadjuvant chemotherapy Overall survival pAKT Prognostic factors Phospho-p44/42 Relapse-free survival;

机译：乳腺癌;HER2 / neu;新辅助化疗;总生存期;pAKT;预后因素;磷酸化p44 / 42;无复发生存;

相似文献

外文文献
中文文献
专利

1. Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy [J] . Liang Huang, Tianwen Chen, Canming Chen, World Journal of Surgical Oncology . 2013,第1期

机译：Phospho-p44 / 42和pAKT在以蒽环类为基础的新辅助化疗治疗的HER2阳性局部晚期乳腺癌患者中的预后和预测价值
2. The Predictive and Prognostic Role of Topoisomerase Hoc and Tissue Inhibitor of Metalloproteinases 1 Expression in Locally Advanced Breast Carcinoma of Egyptian Patients Treated With Anthracycline-based Neoadjuvant Chemotherapy [J] . Hala S. El Rebey, Hayam A. S. Aiad, Iman L. Abulkheir, Applied immunohistochemistry and molecular morphology: AIMM . 2016,第3期

机译：基于蒽环类新辅助化疗治疗埃及患者局部晚期乳腺癌中拓扑异构酶Hoc和金属蛋白酶1表达的组织抑制剂的预测和预后作用。
3. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy [J] . E Brain, C Garrino, J-L Misset, British Journal of Cancer . 1997,第9期

机译：蒽环类新辅助化疗治疗107例II / III期乳腺癌患者的长期预后和预测因素
4. Clinical implications of HER-2 and p53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer [C] . World congress on breast diseases . 2008

机译：HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. [O] . E. Brain, C. Garrino, J. L. Misset, 1997

机译：107例以蒽环类为基础的新辅助化疗治疗的II / III期乳腺癌患者的长期预后和预测因素。
7. Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy [O] . 2013

机译：Phospho-p44 / 42和pAKT在以蒽环类为基础的新辅助化疗治疗的HER2阳性局部晚期乳腺癌患者中的预后和预测价值

Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅